ROCKVILLE, Md.--(BUSINESS WIRE)--Neuralstem, Inc. (NYSE Amex: CUR) today announced that it has received notice of allowance from the United States Patent and Trademark Office (USPTO) for its patent entitled “Transplantation of Human Neural Cells For Treatment Of Neurodegenerative Conditions,” number 11/281,640.
